Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Aravive, Inc. (ARAV) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 HOWARD RUDY (CFO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 400,000 options to buy @ $1.67, valued at $668k
02/02/2023 4 Dove Leonard Scott (COO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 400,000 options to buy @ $1.67, valued at $668k
10/27/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/27/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2022 4 Kirk Sigurd (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 Zhang Eric (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 ESHELMAN FREDRIC N (Executive Chairman) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 Ho Peter Tai-Ching (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
09/26/2022 4 Hohneker John (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 97,063 options to buy @ $0.9152, valued at $88.8k
07/05/2022 4 Geller Robert B. (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.
Txns: Granted 200,000 options @ $0.934, valued at $186.8k
07/05/2022 3 Geller Robert B. (Chief Medical Officer) has filed a Form 3 on Aravive, Inc.
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
04/04/2022 4 ESHELMAN FREDRIC N (Executive Chairman of Board) has filed a Form 4 on Aravive, Inc.
Txns: Exercised 4,545,455 options to buy @ $0.0001, valued at $454.5
03/22/2022 4 Dove Leonard Scott (COO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 200,000 options to buy @ $1.89, valued at $378k
03/22/2022 3 Dove Leonard Scott (COO) has filed a Form 3 on Aravive, Inc.
01/25/2022 4 McIntyre Gail Frances (CEO and President) has filed a Form 4 on Aravive, Inc.
Txns: Granted 425,000 options to buy @ $2.18, valued at $926.5k
01/25/2022 4 Shah Vinay (CFO) has filed a Form 4 on Aravive, Inc.
Txns: Granted 175,000 options to buy @ $2.18, valued at $381.5k
01/25/2022 4 Rangwala Reshma (Chief Medical Officer) has filed a Form 4 on Aravive, Inc.
Txns: Granted 175,000 options to buy @ $2.18, valued at $381.5k
01/05/2022 4 ESHELMAN FREDRIC N (Executive Chairman of Board) has filed a Form 4 on Aravive, Inc.
Txns: Granted 4,545,455 options to buy @ $0.0001, valued at $454.5
12/23/2021 4 Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.
Txns: Gifted 48,366 shares @ $0
12/02/2021 4 Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.
Txns: Sold 252 shares @ $3.22, valued at $811.4
Sold 2,954 shares @ $3.22, valued at $9.5k
Sold 39 shares @ $3.22, valued at $125.6
Exercised 12,350 options @ $0.06, valued at $741
Exercised 38,761 options @ $0.24, valued at $9.3k
Exercised 500 options @ $0.24, valued at $120
09/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2021 4 Giaccia Amato (Director) has filed a Form 4 on Aravive, Inc.
Txns: Granted 22,812 options @ $3.97, valued at $90.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy